SEARCH

SEARCH BY CITATION

References

  • Acheson, D.W., Keusch, G.T., Lightowlers, M., and Donohue-Rolfe, A. (1990) Enzyme-linked immunosorbent assay for Shiga toxin and Shiga-like toxin II using P1 glycoprotein from hydatid cysts. J Infect Dis 161: 134137.
  • Acheson, D.W., Moore, R., De Breucker, S., Lincicome, L., Jacewicz, M., Skutelsky, E., et al. (1996) Translocation of Shiga toxin across polarized intestinal cells in tissue culture. Infect Immun 64: 32943300.
  • Bergan, J., Dyve Lingelem, A.B., Simm, R., Skotland, T., and Sandvig, K. (2012) Shiga toxins. Toxicon 60: 10851107.
  • Bielaszewska, M., Mellmann, A., Zhang, W., Kock, R., Fruth, A., Bauwens, A., et al. (2011) Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis 11: 671676.
  • Björk, S., Breimer, M.E., Hansson, G.C., Karlsson, K.A., and Leffler, H. (1987) Structures of blood group glycosphingolipids of human small intestine. A relation between the expression of fucolipids of epithelial cells and the ABO, Le and Se phenotype of the donor. J Biol Chem 262: 67586765.
  • Boerlin, P., McEwen, S.A., Boerlin-Petzold, F., Wilson, J.B., Johnson, R.P., and Gyles, C.L. (1999) Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 37: 497503.
  • Brigotti, M., Carnicelli, D., Arfilli, V., Rocchi, L., Ricci, F., Pagliaro, P., et al. (2011) Change in conformation with reduction of alpha-helix content causes loss of neutrophil binding activity in fully cytotoxic Shiga toxin 1. J Biol Chem 286: 3451434521.
  • Cornick, N.A., Jelacic, S., Ciol, M.A., and Tarr, P.I. (2002) Escherichia coli O157:H7 infections: discordance between filterable fecal shiga toxin and disease outcome. J Infect Dis 186: 5763.
  • Cottet, S., Corthesy-Theulaz, I., Spertini, F., and Corthesy, B. (2002) Microaerophilic conditions permit to mimic in vitro events occurring during in vivo Helicobacter pylori infection and to identify Rho/Ras-associated proteins in cellular signaling. J Biol Chem 277: 3397833986.
  • Croxen, M.A., and Finlay, B.B. (2010) Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol 8: 2638.
  • Endo, Y., Tsurugi, K., Yutsudo, T., Takeda, Y., Ogasawara, T., and Igarashi, K. (1988) Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 171: 4550.
  • Engedal, N., Skotland, T., Torgersen, M.L., and Sandvig, K. (2011) Shiga toxin and its use in targeted cancer therapy and imaging. Microb Biotechnol 4: 3246.
  • Etienne-Mesmin, L., Chassaing, B., Sauvanet, P., Denizot, J., Blanquet-Diot, S., Darfeuille-Michaud, A., et al. (2011) Interactions with M cells and macrophages as key steps in the pathogenesis of enterohemorrhagic Escherichia coli infections. PLoS ONE 6: e23594. doi:10.1371/journal.pone.0023594.
  • Gobert, A.P., Vareille, M., Glasser, A.L., Hindré, T., de Sablet, T., and Martin, C. (2007) Shiga toxin produced by enterohemorrhagic Escherichia coli inhibits PI3K/NF-kappaB signaling pathway in globotriaosylceramide-3-negative human intestinal epithelial cells. J Immunol 178: 81688174.
  • Gunsalus, R.P., and Park, S.J. (1994) Aerobic-anaerobic gene regulation in Escherichia coli: control by the ArcAB and Fnr regulons. Res Microbiol 145: 437450.
  • He, G., Shankar, R.A., Chzhan, M., Samouilov, A., Kuppusamy, P., and Zweier, J.L. (1999) Noninvasive measurement of anatomic structure and intraluminal oxygenation in the gastrointestinal tract of living mice with spatial and spectral EPR imaging. Proc Natl Acad Sci USA 96: 45864591.
  • Heuvelink, A.E., van de Kar, N.C., Meis, J.F., Monnens, L.A., and Melchers, W.J. (1995) Characterization of verocytotoxin-producing Escherichia coli O157 isolates from patients with haemolytic uraemic syndrome in Western Europe. Epidemiol Infect 115: 114.
  • Hicks, S., Candy, D.C., and Phillips, A.D. (1996) Adhesion of enteroaggregative Escherichia coli to pediatric intestinal mucosa in vitro. Infect Immun 64: 47514760.
  • Holgersson, J., Jovall, P.A., and Breimer, M.E. (1991) Glycosphingolipids of human large intestine: detailed structural characterization with special reference to blood group compounds and bacterial receptor structures. J Biochem (Tokyo) 110: 120131.
  • Hughes, A.K., Ergonul, Z., Stricklett, P.K., and Kohan, D.E. (2002) Molecular basis for high renal cell sensitivity to the cytotoxic effects of Shigatoxin-1: upregulation of globotriaosylceramide expression. J Am Soc Nephrol 13: 22392245.
  • Hurley, B.P., Jacewicz, M., Thorpe, C.M., Lincicome, L.L., King, A.J., Keusch, G.T., et al. (1999) Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells. Infect Immun 67: 66706677.
  • Hurley, B.P., Thorpe, C.M., and Acheson, D.W. (2001) Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration. Infect Immun 69: 61486155.
  • In, J., Lukyanenko, V., Foulke-Abel, J., Hubbard, A.L., Delannoy, M., Hansen, A.M., et al. (2013) Serine protease EspP from enterohemorrhagic Escherichia coli is sufficient to induce Shiga toxin macropinocytosis in intestinal epithelium. PLoS ONE 8: e69196. doi:10.1371/journal.pone.0069196.
  • Ivanov, A.I., Hunt, D., Utech, M., Nusrat, A., and Parkos, C.A. (2005) Differential roles for actin polymerization and a myosin II motor in assembly of the epithelial apical junctional complex. Mol Biol Cell 16: 26362650.
  • Jones, S.A., Chowdhury, F.Z., Fabich, A.J., Anderson, A., Schreiner, D.M., House, A.L., et al. (2007) Respiration of Escherichia coli in the mouse intestine. Infect Immun 75: 48914899.
  • Karmali, M.A., Steele, B.T., Petric, M., and Lim, C. (1983) Sporadic cases of haemolytic uremic syndrome associated with faecal cytotoxin and cytotoxin producing Escherichia coli in stools. Lancet 1: 619620.
  • Karmali, M.A., Petric, M., Lim, C., Fleming, P.C., Arbus, G.S., and Lior, H. (1985) The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 151: 775782.
  • Kendall, M.M., Gruber, C.C., Parker, C.T., and Sperandio, V. (2012) Ethanolamine controls expression of genes encoding components involved in interkingdom signaling and virulence in enterohemorrhagic Escherichia coli O157:H7. mBio 3: pii: e50pii: e12. doi:10.1128/mBio.00050-12.
  • Kolling, G.L., and Matthews, K.R. (1999) Export of virulence genes and Shiga toxin by membrane vesicles of Escherichia coli O157:H7. Appl Environ Microbiol 65: 18431848.
  • Kovbasnjuk, O., Mourtazina, R., Baibakov, B., Wang, T., Elowsky, C., Choti, M.A., et al. (2005) The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer. Proc Natl Acad Sci USA 102: 1908719092.
  • Lingwood, C.A., Law, H., Richardson, S., Petric, M., Brunton, J.L., De Grandis, S., et al. (1987) Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem 262: 88348839.
  • Lukyanenko, V., Malyukova, I., Hubbard, A., Delannoy, M., Boedeker, E., Zhu, C., et al. (2011) Enterohemorrhagic Escherichia coli infection stimulates Shiga toxin 1 macropinocytosis and transcytosis across intestinal epithelial cells. Am J Physiol Cell Physiol 301: C1140C1149.
  • Madara, J.L., Stafford, J., Barenberg, D., and Carlson, S. (1988) Functional coupling of tight junctions and microfilaments in T84 monolayers. Am J Physiol 254: G416G423.
  • Malyukova, I., Murray, K.F., Zhu, C., Boedeker, E., Kane, A., Patterson, K., et al. (2009) Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis. Am J Physiol Gastrointest Liver Physiol 296: G78G92.
  • Marteyn, B., West, N.P., Browning, D.F., Cole, J.A., Shaw, J.G., Palm, F., et al. (2010) Modulation of Shigella virulence in response to available oxygen in vivo. Nature 465: 355358.
  • Marteyn, B., Scorza, F.B., Sansonetti, P.J., and Tang, C. (2011) Breathing life into pathogens: the influence of oxygen on bacterial virulence and host responses in the gastrointestinal tract. Cell Microbiol 13: 171176.
  • Mills, D.C., Gundogdu, O., Elmi, A., Bajaj-Elliott, M., Taylor, P.W., Wren, B.W., et al. (2012) Increase in Campylobacter jejuni invasion of intestinal epithelial cells under low-oxygen coculture conditions that reflect the in vivo environment. Infect Immun 80: 16901698.
  • Money, P., Kelly, A.F., Gould, S.W., Denholm-Price, J., Threlfall, E.J., and Fielder, M.D. (2010) Cattle, weather and water: mapping Escherichia coli O157:H7 infections in humans in England and Scotland. Environ Microbiol 12: 26332644.
  • Mühldorfer, I., Hacker, J., Keusch, G.T., Acheson, D.W., Tschäpe, H., Kane, A., V, et al. (1996) Regulation of the Shiga-like toxin II operon in Escherichia coli. Infect Immun 64: 495502.
  • Müsken, A., Bielaszewska, M., Greune, L., Schweppe, C.H., Müthing, J., Schmidt, H., et al. (2008) Anaerobic conditions promote expression of Sfp fimbriae and adherence of sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM to human intestinal epithelial cells. Appl Environ Microbiol 74: 10871093.
  • Nataro, J.P., Hicks, S., Phillips, A.D., Vial, P.A., and Sears, C.L. (1996) T84 cells in culture as a model for enteroaggregative Escherichia coli pathogenesis. Infect Immun 64: 47614768.
  • Ostroff, S.M., Griffin, P.M., Tauxe, R.V., Shipman, L.D., Greene, K.D., Wells, J.G., et al. (1990) A statewide outbreak of Escherichia coli O157:H7 infections in Washington State. Am J Epidemiol 132: 239247.
  • Philpott, D.J., Ackerley, C.A., Kiliaan, A.J., Karmali, M.A., Perdue, M.H., and Sherman, P.M. (1997) Translocation of verotoxin-1 across T84 monolayers: mechanism of bacterial toxin penetration of epithelium. Am J Physiol 273: 13491358.
  • Pickering, L.K., Obrig, T.G., and Stapleton, F.B. (1994) Hemolytic uremic syndrome and enterohemorrhagic Escherichia coli. Pediatr Infect Dis J 13: 459476.
  • Polzin, S., Huber, C., Eylert, E., Elsenhans, I., Eisenreich, W., and Schmidt, H. (2013) Growth media simulating Ileal and colonic environments affect the intracellular proteome and carbon fluxes of enterohemorrhagic Escherichia coli O157:H7 strain EDL933. Appl Environ Microbiol 79: 37033715.
  • Rasko, D.A., Webster, D.R., Sahl, J.W., Bashir, A., Boisen, N., Scheutz, F., et al. (2011) Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. N Engl J Med 365: 709717.
  • Riley, L.W., Remis, R.S., Helgerson, S.D., McGee, H.B., Wells, J.G., Davis, B.R., et al. (1983) Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 308: 681685.
  • Ritchie, J.M., Wagner, P.L., Acheson, D.W., and Waldor, M.K. (2003) Comparison of Shiga toxin production by hemolytic-uremic syndrome-associated and bovine-associated Shiga toxin-producing Escherichia coli isolates. Appl Environ Microbiol 69: 10591066.
  • de Sablet, T., Chassard, C., Bernalier-Donadille, A., Vareille, M., Gobert, A.P., and Martin, C. (2009) Human microbiota-secreted factors inhibit shiga toxin synthesis by enterohemorrhagic Escherichia coli O157:H7. Infect Immun 77: 783790.
  • Schüller, S. (2011) Shiga toxin interaction with human intestinal epithelium. Toxins 3: 626639.
  • Schüller, S., and Phillips, A.D. (2010) Microaerobic conditions enhance type III secretion and adherence of enterohaemorrhagic Escherichia coli to polarized human intestinal epithelial cells. Environ Microbiol 12: 24262435.
  • Schüller, S., Frankel, G., and Phillips, A.D. (2004) Interaction of Shiga toxin from Escherichia coli with human intestinal epithelial cell lines and explants: Stx2 induces epithelial damage in organ culture. Cell Microbiol 6: 289301.
  • Schüller, S., Heuschkel, R., Torrente, F., Kaper, J.B., and Phillips, A.D. (2007) Shiga toxin binding in normal and inflamed human intestinal mucosa. Microbes Infect 9: 3539.
  • Shimizu, T., Ohta, Y., and Noda, M. (2009) Shiga toxin 2 is specifically released from bacterial cells by two different mechanisms. Infect Immun 77: 28132823.
  • Shimizu, T., Ohta, Y., Tsutsuki, H., and Noda, M. (2011) Construction of a novel bioluminescent reporter system for investigating Shiga toxin expression of enterohemorrhagic Escherichia coli. Gene 478: 110.
  • Strockbine, N.A., Marques, L.R., Newland, J.W., Smith, H.W., Holmes, R.K., and O'Brien, A.D. (1986) Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect Immun 53: 135140.
  • Tarr, P.I., Gordon, C.A., and Chandler, W.L. (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365: 10731086.
  • Tesh, V.L. (2012) Activation of cell stress response pathways by Shiga toxins. Cell Microbiol 14: 19.
  • Tyler, J.S., Beeri, K., Reynolds, J.L., Alteri, C.J., Skinner, K.G., Friedman, J.H., et al. (2013) Prophage induction is enhanced and required for renal disease and lethality in an EHEC mouse model. PLoS Pathog 9: e1003236. doi:10.1371/journal.ppat.1003236.
  • Vareille, M., de Sablet, T., Hindré, T., Martin, C., and Gobert, A.P. (2007) Nitric oxide inhibits Shiga-toxin synthesis by enterohemorrhagic Escherichia coli. Proc Natl Acad Sci USA 104: 1019910204.
  • Viswanathan, V.K., Hodges, K., and Hecht, G. (2009) Enteric infection meets intestinal function: how bacterial pathogens cause diarrhoea. Nat Rev Microbiol 7: 110119.
  • Wagner, P.L., Acheson, D.W., and Waldor, M.K. (2001a) Human neutrophils and their products induce Shiga toxin production by enterohemorrhagic Escherichia coli. Infect Immun 69: 19341937.
  • Wagner, P.L., Neely, M.N., Zhang, X., Acheson, D.W., Waldor, M.K., and Friedman, D.I. (2001b) Role for a phage promoter in Shiga toxin 2 expression from a pathogenic Escherichia coli strain. J Bacteriol 183: 20812085.
  • Wagner, P.L., Livny, J., Neely, M.N., Acheson, D.W., Friedman, D.I., and Waldor, M.K. (2002) Bacteriophage control of Shiga toxin 1 production and release by Escherichia coli. Mol Microbiol 44: 957970.
  • Wong, A.R., Pearson, J.S., Bright, M.D., Munera, D., Robinson, K.S., Lee, S.F., et al. (2011) Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol Microbiol 80: 14201438.
  • Wong, C.S., Mooney, J.C., Brandt, J.R., Staples, A.O., Jelacic, S., Boster, D.R., et al. (2012) Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin Infect Dis 55: 3341.
  • Zumbrun, S.D., Hanson, L., Sinclair, J.F., Freedy, J., Melton-Celsa, A.R., Rodriguez-Canales, J., et al. (2010) Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide. Infect Immun 78: 44884499.